ProPhase Labs, Inc. (PRPH) Return on equity 2016–2025
ProPhase Labs, Inc. (PRPH) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-420.3%FY2025 · since FY2016: -48.1% → -420.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -420.3% | +305.5 pp |
| FY2024 | -725.7% | -691.8 pp |
| FY2023 | -34.0% | -63.0 pp |
| FY2022 | 29.0% | +18.3 pp |
| FY2021 | 10.7% | +30.8 pp |
| FY2020 | -20.1% | +7.9 pp |
| FY2019 | -28.0% | -17.5 pp |
| FY2018 | -10.5% | -138.0 pp |
| FY2017 | 127.4% | +175.6 pp |
| FY2016 | -48.1% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More PRPH financial trends
PRPH RevenuePRPH Net incomePRPH Net marginPRPH Gross profitPRPH Gross marginPRPH Operating incomePRPH Operating marginPRPH Operating cash flowPRPH Free cash flowPRPH Capital expendituresPRPH Stock buybacksPRPH Dividends paidPRPH Total assetsPRPH Total liabilitiesPRPH Shareholders’ equityPRPH overview →